Invention Grant
US07321033B2 3-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereof
有权
3-B-D-呋喃核糖基噻唑并[4,5-d]嘧啶核苷及其用途
![3-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereof](/docs/US/2008-01-22/US07321033B2/abs.jpg.600x600.jpg)
- Patent Title: 3-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereof
- Patent Title (中): 3-B-D-呋喃核糖基噻唑并[4,5-d]嘧啶核苷及其用途
-
Application No.: US10861430Application Date: 2004-06-07
-
Publication No.: US07321033B2Publication Date: 2008-01-22
- Inventor: Devron R. Averett , Stephen E. Webber , Joseph R. Lennox , Erik J. Rueden , David Louis Clark , Alan Xin Xiang
- Applicant: Devron R. Averett , Stephen E. Webber , Joseph R. Lennox , Erik J. Rueden , David Louis Clark , Alan Xin Xiang
- Applicant Address: US CA San Diego
- Assignee: Anadys Pharmaceuticals, Inc.
- Current Assignee: Anadys Pharmaceuticals, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Connolly Bove Lodge & Hutz LLP
- Main IPC: C07H19/00
- IPC: C07H19/00 ; C07H19/044 ; C07D239/00 ; C07D239/70 ; C07D471/00 ; C07D487/00 ; C07D491/00 ; C07D239/02 ; A01N43/90 ; A61K31/519
![3-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereof](/abs-image/US/2008/01/22/US07321033B2/abs.jpg.150x150.jpg)
Abstract:
The invention is directed to 3-β-D-ribofuranosylthiazolo[4,5-d]pyridimine nucleosides and pharmaceutical compositions containing such compounds that have immunomodulatory activity. The invention is also directed to the therapeutic or prophylactic use of such compounds and compositions, and to methods of treating diseases and disorders described herein, by administering effective amounts of such compounds.
Public/Granted literature
- US20050070556A1 3-B-D-ribofuranosylthiazolo [4,5-d] pyridimine nucleosides and uses thereof Public/Granted day:2005-03-31
Information query
